About Paul Kedrosky
|
| Dr. Kedrosky is currently the Executive Director of the William J. von Liebig Center in San Diego, California. Using an innovative seed capital program, the Center catalyzes the commercialization of technologies from the internationally-ranked University of California, San Diego. Dr. Kedrosky is also a venture investor with Ventures West, Canada's largest institutional venture capital firm, where he is most active in consumer technologies and software. He is currently on the board of Marqui Corporation, a marketing automation software company. |
Recent Article:
Venture Capital & Picking vs. Poking
- For more on Paul Kedrosky visit paul.kedrosky.com
There is lots of partner tribalism in venture capital, but one worth noting is the schism between pickers and pokers.
Most IT investors think biotech investors are "mere" pickers. In other words, to the extent said biotech VCs are successful it is because they get behind the right technology/platform/people and ride it. To that way of thinking, your average biotech venture investor is going to do diddly to assist a typical investee -- sit at a bench, and stain my blue shirt? be serious! -- so they are, at least from the perspective of their non-biotech VC brethren, pickers. All the work is in the picking, and once they have done their 1.5 investments that year they might as well go on holidays.
Following the same stereotype along, most venture investors see themselves as pokers. That is, they poke, and probe, and cajole, and generally try to push the company in a direction that they, in their wisdom, think is the right one for said company. Information tech venture investors see themselves as pokers, and look down their noses somewhat at biotech sorts as mere pickers.
So who's right? Both and neither. While there is no doubt adept investors can add value now and then, the reality is, I'm increasingly convinced, that 90% of the value in venture investing comes at the picking stage. Don't tell anyone, but so long as you fire incompetent people, act impatient now and then at board meetings about progress and spending, and otherwise generally stay out of the way, you're probably better off following the medical dictum of "first, do no harm".
The preceding will annoy lots of smart people I know. They like to think their 2% of asset management fee pays for more than just making a good private equity stock pick and then getting the hell out of the way, but it doesn't (other than in true seed investing, which is a very different business).
In the debate between pickers and pokers you don't always win with with good pickers, but that's definitely the way to bet your money.
Like this article? Share it with your friends
 |
Related Articles |
|
Venture Capital & Picking vs. Poking
|
| |
There is lots of partner tribalism in venture capital, but one worth noting is the schism between pickers and pokers.
|
Why should Venture Capitalists invest in SME's in Africa?
|
| |
Africa is at the dawn of a new renaissance, if you want a high return on your capital, you should include Africa in your portfolio. I'm not only going to invest in Africa because I'm African, but because this is the...
|
Venture Capital & Recessions
|
| |
Lots of talk in the venture business, as everywhere else, about the impact of recessions on the business. In general, recession vintage venture funds have been among the better-performing funds. Here are some relate...
|
Phrase du Jour: Venture Tourist
|
| |
Here is my venture capital phrase of the day, complete with definition:
|
“Tips For Entrepreneurs In Selecting A Venture Capitalist”
|
| |
As a business coach, I do get the opportunity from time to time to assist, guide and facilitate the search for venture capital and venture capital firms. Recently I have been involved in doing just that and here ar...
|
|
|
More
Paul Kedrosky


|
|